Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.
about
Genetics and biology of pancreatic ductal adenocarcinomaDevelopmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular OriginAlterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical ImplicationsEpigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?Regulation of Cellular Identity in CancerEpigenetic regulation of epithelial-mesenchymal transitionBRG1 promotes hepatocarcinogenesis by regulating proliferation and invasivenessPan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinomaCombined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinomaTargeting BET bromodomain proteins in solid tumorsBET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo.Stromal cues regulate the pancreatic cancer epigenome and metabolome.Neat1 is a p53-inducible lincRNA essential for transformation suppression.Targeting Transcriptional and Epigenetic Reprogramming in Stromal Cells in Fibrosis and Cancer.Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor.Exploiting receptor tyrosine kinase co-activation for cancer therapy.New insights in the development of pancreatic cancer.Cells of origin of pancreatic neoplasms.Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts.Differentiation and Inflammation: 'Best Enemies' in Gastrointestinal Carcinogenesis.ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation.Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis.Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma development.Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer.Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma.Pancreatic cancer: A matter of timing.Arid1a restrains Kras-dependent changes in acinar cell identity.The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesisEpigenetics of gastrointestinal diseases: notes from a workshopSCF-mediated degradation of Brg1 suppresses gastric cancer metastasis
P2860
Q26765438-C1306A82-10D7-4A47-BC6B-8A92CD252F9AQ26774942-49C6E8EC-E1FA-4379-892D-4DB3E227AB37Q28074465-048A0FE6-66F8-4F3E-ADE0-2915B79A1DD1Q28076548-F1A06E13-2180-40D3-BB56-A47CF2D33010Q28086849-57EC58FA-2A29-4C23-BE4A-5AB36A11A7EEQ33764436-D50DC89C-1AEB-4961-BFED-408BE47427D2Q33898452-FD0EFC11-2B26-4774-924F-D1D108ED38BDQ34545220-5BE5D1AF-C334-4D6F-880F-2367A8F1F86CQ36103351-3F53E957-BD72-44D3-B9C0-FD1654B81665Q37123636-4723F5B9-A8E0-4184-972F-E13AAFC1E7C6Q37619860-E0A9031A-7F6D-4761-9168-B51169775A33Q37624355-6AB60D68-D195-4431-997E-C86F780F32AEQ37626183-3782A91A-9D43-4A3E-8DD0-7AA2C6F86A15Q38683437-490438C8-7A24-43E3-9830-D55C75894349Q38708376-2EFCAF31-65CB-4621-AAEA-E205939E46A5Q38712272-E30C4A5A-2732-4946-BF74-284CEBB314DEQ38906990-987A6C85-A7EF-4412-AA6D-6F9305DED7B1Q38907393-0E313654-EA0E-463E-9220-8FF0D55C78ADQ39161835-06909010-8934-448A-ACC9-634CAF4E10B4Q39204274-C065350B-2458-48C1-A508-3AFA293C0616Q39384816-1F07ED88-1912-439A-A148-5345BFA28671Q41931284-22839B66-251F-4431-83AF-E8F20EE61080Q46867228-2695DBBC-674A-4080-9952-C03CE29D20B9Q47107794-BE1A20DA-B486-4132-BE49-36571F1BDE3BQ47156096-DFE2BCF2-31FE-4382-9294-96F52B999927Q47404707-87F2934E-1ABC-461F-935D-48A1253A88C7Q50640303-5FB75128-E5AB-42BB-9046-3922EE469E65Q50891398-8A99DC4E-5874-412F-8CC5-76A9DBD1EDC5Q53221035-5F55E9F4-FE93-473F-A2A9-AAC0F15A36DDQ55713410-8E0F705C-3F0D-43D0-995A-4B48819A49F8Q56967209-C02B79FE-79E9-428B-9101-A87252DE3428Q57179338-4A10CF5B-7A7A-4150-9D37-D71DB30B564FQ57753119-FB36C925-9BEA-4BD0-8C97-074ADBF0D8A0
P2860
Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Brg1 promotes both tumor-suppr ...... f pancreatic cancer formation.
@ast
Brg1 promotes both tumor-suppr ...... f pancreatic cancer formation.
@en
type
label
Brg1 promotes both tumor-suppr ...... f pancreatic cancer formation.
@ast
Brg1 promotes both tumor-suppr ...... f pancreatic cancer formation.
@en
prefLabel
Brg1 promotes both tumor-suppr ...... f pancreatic cancer formation.
@ast
Brg1 promotes both tumor-suppr ...... f pancreatic cancer formation.
@en
P2093
P2860
P356
P1433
P1476
Brg1 promotes both tumor-suppr ...... f pancreatic cancer formation.
@en
P2093
Atsushi Urano
David W Dawson
E Scott Seeley
Eric A Collisson
Guido Von Figura
Karina E Villanueva
Matthias Hebrok
Nilotpal Roy
Shivani Malik
Xinyuan Lu
P2860
P304
P356
10.1101/GAD.256628.114
P577
2015-03-01T00:00:00Z